Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years because of Washington's request for confidential biological samples.
The decision came to light after a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesperson later explained that the United States was demanding access to biological samples for research and profit while refused to guarantee the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more dialogue to find a agreement agreeable to both sides so the nation's critical HIV programme can proceed.
Broader Implications
This rejection comes after a comparable situation in neighbouring Kenya, where a high court suspended a related health funding agreement after concerns were filed about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had administered assistance for the American government, but Trump stated its spending was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date agreed to these new agreements, representing over $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data indefinitely, without any corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"In essence, our nation would supply the raw materials for medical research without any certainty that the resulting innovations would be accessible to our citizens should a future pandemic arise."
Sovereignty and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks already established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This framework is intended to ensure that when a country contributes its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
These objections over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to continued discussions with our US partners on how subsequent co-operation might be arranged in a way that respects the independence and dignity of both nations."
Health Experts Response
A leading public health body expressed it recognised the government's concerns, but suggested that talks must proceed since much of the nation's HIV programmes depended on external financing.
"In cases where specific concerns arise, such as those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the continuing challenges between accepting crucial international aid and protecting national sovereignty in an ever more data-driven world.